Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - PHOENIX MEDICAL SOFTWARE, INC. | Financial_Report.xls |
| EX-31.1 - CERTIFICATION - PHOENIX MEDICAL SOFTWARE, INC. | ex31one.htm |
| EX-32.1 - CERTIFICATION - PHOENIX MEDICAL SOFTWARE, INC. | ex32one.htm |
| EX-31.2 - CERTIFICATION - PHOENIX MEDICAL SOFTWARE, INC. | ex31two.htm |
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
(Mark One)
[ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2011
OR
[ ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934
From the transition period from ___________ to ____________
Commission File Number 000-51750
PHOENIX MEDICAL SOFTWARE, INC.
(Exact name of small business issuer as specified in its charter)
| Nevada | 20-4846807 |
| (State or other jurisdiction of incorporation or organization) | (IRS Employer Identification No.) |
604 Creekview, Ovilla, Texas 75154
(Address of principal executive offices)
(800) 843-8179
(Issuer's telephone number)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:. Yes [ X ] No [ ].
Indicate by a check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” ”accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
| Large Accelerated Filer [ ] | Accelerated Filer [ ] | ||
| Non-Accelerated Filer [ ] | Smaller Reporting Company [X] |
Indicate by a check mark whether the company is a shell company (as defined by Rule 12b-2 of the Exchange Act: Yes [ ] No [X].
As of November 21, 2011 there were 9,663,667 shares of Common Stock of the issuer outstanding.
EXPLANATORY NOTE
The purpose of this Form 10-Q/A to Phoenix Medical Software, Inc.'s Quarterly Report on Form 10-Q for the quarter ended September 30, 2011, filed with the Securities and Exchange Commission on November 21, 2011 (the "Form 10-Q"), is to correct certain typographical errors in the Statement of Cash Flows.
No other changes have been made to the Form 10-Q previously filed. This Amendment speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date and does not modify or update in any way disclosures made in the original Form 10-Q.
In addition, pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as a result of this Amended Report, the certifications pursuant to Section 302 and Section 906 of the Sarbanes-Oxley Act of 2002, filed and furnished, respectively as exhibits to the Original Report have been re-executed and re-filed as of the date of this Amended Report and are included as exhibits hereto.
| 2 |
| PHOENIX MEDICAL SOFTWARE, INC. |
| (FORMERLY TRIPLE AMEDICAL, INC.) |
| CONSOLIDATED STATEMENTS OF CASH FLOWS |
| For the Nine Months Ended September 30, 2011 and 2010 |
| (Unaudited) |
| Nine Months Ended | ||||||||
| September 30, | ||||||||
| 2011 | 2010 | |||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
| Net loss | $ | (99,363 | ) | $ | (156,210 | ) | ||
| Adjustments to reconcile net loss to net | ||||||||
| cash used in operating activities: | ||||||||
| Depreciation and amortization | 57,385 | 63,546 | ||||||
| Stock issued for services | 22,500 | 85,000 | ||||||
| Bad debt expense | 230,634 | 51,820 | ||||||
| Change in operating assets and liabilities: | ||||||||
| Accounts receivable | (341,922 | ) | (205,587 | ) | ||||
| Accounts payable and accrued expenses | 14,633 | 38,314 | ||||||
| NET CASH USED IN OPERATING ACTIVITIES | (116,133 | ) | (123,117 | ) | ||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
| Transfer of cash in sale of subsidiary | (117,016 | ) | — | |||||
| NET CASH PROVIDED USED IN INVESTING ACTIVITIES | (117,016 | ) | — | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
| Proceeds from sale of stock, including stock subscription deposits | — | 17,625 | ||||||
| Payments on line of credit | — | (3,865 | ) | |||||
| Borrowings on line of credit | 25,000 | |||||||
| Advances from shareholder | — | 3,500 | ||||||
| Payments to shareholder | (14,199 | ) | (22,910 | ) | ||||
| NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES | 10,801 | (5,650 | ) | |||||
| NET DECREASE IN CASH | (222,348 | ) | (128,767 | ) | ||||
| CASH, BEGINNING OF PERIOD | 222,348 | 132,993 | ||||||
| CASH, END OF PERIOD | $ | — | $ | 4,226 | ||||
| NON-CASH TRANSACTIONS | ||||||||
| Common stock issued for conversion of debt | $ | — | $ | 15,000 | ||||
| Gain on sale of subsidiary | 54,443 | — | ||||||
| SUPPLEMENTAL DISCLOSURES | ||||||||
| Interest paid | $ | — | $ | — | ||||
| Income taxes paid | — | — | ||||||
See accompanying summary of accounting policies and notes to unaudited consolidated financial statements
| 3 |
SIGNATURES
In accordance with the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
PHOENIX MEDICAL SOFTWARE, INC.
By /s/ P. Morgan McCune
P. Morgan McCune, President, CFO
Date: November 29, 2011
| 4 |